Soleno Therapeutics, Inc.
Price Action
Technical Summary
WEAKENINGSoleno Therapeutics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 64), indicating performance broadly in line with the market. Earnings growth of 163% provides fundamental context to the price action. However, with RSI at 77, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $52.74 | +0.39% | ABOVE |
| 50 SMA | $43.54 | +21.59% | ABOVE |
| 100 SMA | $43.62 | +21.38% | ABOVE |
| 150 SMA | $47.93 | +10.46% | ABOVE |
| 200 SMA | $53.72 | -1.45% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SLNO in an uptrend right now?
SLNO has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is SLNO overbought or oversold?
SLNO's RSI (14) is 77. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is SLNO outperforming the market?
SLNO has a Relative Strength (RS) Rating of 64 out of 99. SLNO is performing about average compared to the market.
Where is SLNO in its 52-week range?
SLNO is trading at $52.94, which is 59% of its 52-week high ($90.32) and 39% above its 52-week low ($29.47).
How volatile is SLNO?
SLNO has a Beta of 0.92 and 52-week volatility of 69%. It's less volatile than the S&P 500 - generally more stable.